North America Leads the Microsphere Drug Market Amid Strong R&D Investment
North America has established itself as a dominant force in the global Microsphere Drug Market, driven by advanced healthcare infrastructure, significant research and development investment, and the presence of leading pharmaceutical companies. The region accounted for a substantial share in 2024, valued at approximately USD 1.2 billion, and is projected to reach USD 2.1 billion by 2035. The...
0 Commentaires 0 Parts 0 Aperçu